Ultrasound for Pre-operative Evaluation of Well Differentiated Thyroid Cancer

Similar documents
Pre-operative Ultrasound of Lymph Nodes in Thyroid Cancer

Preoperative Evaluation

Gerard M. Doherty, MD

2015 American Thyroid Association Thyroid Nodule and Cancer Guidelines

Dynamic Risk Stratification:

Reoperative central neck surgery

Persistent & Recurrent Differentiated Thyroid Cancer

Management of Recurrent Thyroid Cancer

4/22/2010. Hakan Korkmaz, MD Assoc. Prof. of Otolaryngology Ankara Dıșkapı Training Hospital-Turkey.

Thyroid Surgery: Lobectomy, total thyroidectomy, LN biopsies or only watchful waiting?

How Will (Should) the Latest Guidelines Affect the Endocrinologist s Management of Thyroid Cancer? AACE 2017

Thyroid Nodule. Disclosure. Learning Objectives P A P A P A 3/18/2014. Nothing to disclose.

The International Federation of Head and Neck Oncologic Societies. Current Concepts in Head and Neck Surgery and Oncology

Well Differen*ated Thyroid Microcarcinoma. Robert A. Levine, MD, FACE, ECNU Thyroid Center of New Hampshire Geisel School of Medicine at Dartmouth

Prophylactic Central Compartment Neck Dissection(CCND) for Papillary Thyroid Cancer: Con

Differentiated Thyroid Cancer: Initial Management

Thyroid Cancer: When to Treat? MEGAN R. HAYMART, MD

Thyroid US. Background: Thyroid/Neck US. Use of Office Ultrasound in the Thyroid Surgery Practice

THYROID CANCER IN CHILDREN. Humberto Lugo-Vicente MD FACS FAAP Professor Pediatric Surgery UPR School of Medicine

How good are we at finding nodules? Thyroid Nodules Thyroid Cancer Epidemiology Initial management Long-term follow up Disease-free status

The International Federation of Head and Neck Oncologic Societies. Current Concepts in Head and Neck Surgery and Oncology

Long-term Follow-up for Patients with Papillary Thyroid Carcinoma Treated as Benign Nodules

Thyroid Gland. Protocol applies to all malignant tumors of the thyroid gland, except lymphomas.

Current Issues in Thyroid Cancer Surgery in 2017

Thyroid INTRODUCTION ANATOMY SUMMARY OF CHANGES

YCN Thyroid NSSG. *** VALID ON DATE OF PRINTING ONLY - all guidelines available at *** page 1 of 8 version number: 1.

Dilemmas in Cytopathology and Histopathology

40 TH EUROPEAN CONGRESS 0F CYTOLOGY LIVERPOOL, UK October 2-5, 2016

Overview. Extraglandular Thyroid Lymphatics. Management of the Lateral Neck in Well-Differentiated Thyroid Carcinoma. David W. Eisele, M.D., F.A.C.S.

AGGRESSIVE VARIANTS OF PAPILLARY THYROID CARCINOMA DIAGNOSIS AND PROGNOSIS

AACE/ACE Advanced Endocrine Neck Ultrasound Training Course 2016

Differentiated Thyroid Carcinoma

Disclosures Nodal Management in Differentiated Thyroid Carcinoma

New York, the nation s thyroid gland. Christopher Morley ( ), "Shore Leave"

Risk Adapted Follow-Up

Minimalistic Initial Therapy Options For Low Risk Papillary Thyroid Cancer

What s an NIFTP? Keeping Up To Date in Thyroid 2018

Treatment of Cervical Lymph Node Metastases Differentiated Thyroid Cancer

Long Term Follow-Up for Differentiated Thyroid Cancer: The Mayo Experience

WTC 2013 Panel Discussion: Minimal disease

Thyroid Pathology: It starts and ends with the gross. Causes of Thyrophobia. Agenda. Diagnostic ambiguity. Treatment/prognosis disconnect

Management guideline for patients with differentiated thyroid cancer. Teeraporn Ratanaanekchai ENT, KKU 17 October 2007

Imaging in Thyroid Cancer

Evaluation of thyroid isthmusectomy as a potential treatment for papillary thyroid carcinoma limited to the isthmus: A clinical study of 73 patients

PEDIATRIC Ariel Katz MD

Surgical Treatment for Papillary Thyroid Carcinoma in Japan: Differences from Other Countries

Objectives. 1)To recall thyroid nodule ultrasound characteristics that increase the risk of malignancy

Sonographic Features of Thyroid Nodules & Guidelines for Management

Cervical Lymph Nodes

Papillary Thyroid Microcarcinoma Presenting as Horner s Syndrome: A Novel Clinical Presentation

Thyroid nodules - medical and surgical management. Endocrinology and Endocrine Surgery Manchester Royal Infirmary

10/24/2008. Surgery for Well-differentiated Thyroid Carcinoma- The Primary

ELIZABETH CEDARS DR. KOREY HOOD Available September 29

CAP Cancer Protocol and ecc Summary of Changes for August 2014 Thyroid Agile Release

AACE Thyroid Cancer Tumor board 25 years of the Endocrine and Surgery collaboration

Management of Thyroid Nodules

Clinical and Molecular Approach to Using Thyroid Needle Biopsy for Nodular Disease

Strategies for detection of recurrent disease in longterm follow-up of differentiated thyroid cancer

Objectives. How to Investigate Thyroid Nodules like A Pro

Thyroid Nodules: US Risk Stratification. Alex Tessnow, MD, FACE, ECNU University of Texas Southwestern Associate Professor of Medicine Dallas, Texas

- RET/PTC rearrangement: 20% papillary thyroid cancer - RET: medullary thyroid cancer

Shifting Paradigms and Debates in the Management of Well-differentiated Thyroid Cancer

Initial surgery for differentiated thyroid cancer: What is the appropriate extent and attendant risks and benefits?

Case Scenario #1 Larynx

Follicular Derived Thyroid Tumors

3/29/2012. Thyroid cancer- what s new. Thyroid Cancer. Thyroid cancer is now the most rapidly increasing cancer in women

Adina Alazraki, MD, FAAP Assistant Professor Radiology and Pediatrics Emory University and Children s Healthcare of Atlanta

Title. CitationInternational Cancer Conference Journal, 4(1): Issue Date Doc URL. Rights. Type. File Information

Locally advanced papillary thyroid cancer

A variation in recurrence patterns of papillary thyroid cancer with disease progression: A long-term follow-up study

Case Scenario 1: Thyroid

Exercise 15: CSv2 Data Item Coding Instructions ANSWERS

Radiology- Pathology Conference 4/29/2012. Lymph Nodes. John McGrath

Thyroid Ultrasound for the Endocrine Surgeon: A Valuable Clinical Tool that Enhances Diagnostic and Therapeutic Outcomes

Fuqiang Li, Yijun Wu, Liang Chen, Liang Hu, Xiaosun Liu. Original Article

Oncological outcomes for patients with well differentiated thyroid cancer Nixon, I.J.

Advanced Anatomy of the Neck

42 yr old male with h/o Graves disease and prior I 131 treatment presents with hyperthyroidism and undetectable TSH. 2 hr uptake 20%, 24 hr uptake 50%

Case Papillary thyroid carcinoma(ptc):local recurrence post thyroidectomy

Adjuvant therapy for thyroid cancer

Papillary thyroid microcarcinoma: the significance of high risk features

Thyroid nodules. Most thyroid nodules are benign

American Head and Neck Society - Journal Club Volume 22, July 2018

(Not so) New Guidelines for Management of Thyroid Nodules and Differentiated Thyroid Cancer Minnesota/Midwest Chapter of AACE

Pediatric Thyroid Cancer Lung Metastases. Liora Lazar MD

Thyroid Nodules: US Risk Stratification and FNA Guidelines

131-I Therapy Planning in Thyroid Cancer: The role of diagnostic radioiodine scans

B. Environmental Factors. a. The major risk factor to papillary thyroid cancer is exposure to ionizing radiation, during the first 2 decades of life.

Thyroid nodules 3/22/2011. Most thyroid nodules are benign. Thyroid nodules: differential diagnosis

NIFTP: Histopathology of a Cytological Monkey Wrench. B. Wehrli

Review Article Thyroidectomy and Lymph Node Dissection in Papillary Thyroid Carcinoma

Thyroid Nodule Risk Stratification and FNA Guidelines

An Alphabet Soup of Thyroid Neoplasms

I-131 ABLATION AND ADJUVANT THERAPY OF THYROID CANCER

Clinical Study Utility of Surgeon-Performed Ultrasound Assessment of the Lateral Neck for Metastatic Papillary Thyroid Cancer

The Thyroid Nodule: From the Ultrasound Image to the Anatomopathological Diagnosis

Interpreting the Thyroid Ultrasound Report

Management of Neck Metastasis from Unknown Primary

Approach to Thyroid Nodules

Transcription:

Ultrasound for Pre-operative Evaluation of Well Differentiated Thyroid Cancer Its Not Just About the Nodes AACE Advances in Medical and Surgical Management of Thyroid Cancer - 2017 Robert A. Levine, MD, FACE, ECNU Thyroid Center of New Hampshire Geisel School of Medicine at Dartmouth College

Objectives Discuss the impact of the pre-operative ultrasound on surgical planning. Lymph nodes Additional factors in risk stratification. Review features of benign and malignant lymph nodes. Review findings on pre-operative ultrasound associated with high risk of recurrence. Critically analyze the 2015 ATA Guidelines regarding biopsy of suspicious lymph nodes.

Differentiated Thyroid Cancer 62,500 New cases of DTC in 2015 Doubled over last decade Tripled over last two decades. 1,950 Deaths - Stable Mortality not significantly changed over past 30 years Assumption: Early detection and treatment of cervical metastases will affect mortality Mortality versus Morbidity

Cervical Lymph Nodes Approximately 300 lymph nodes in the normal neck. Typically can identify 6 20 nodes by ultrasound. Nodes are more prominent following infections, mononucleosis, dental procedures and in Hashimoto s thyroiditis.

Preoperative Imaging WDTC clinically involves lymph nodes in approximately 15-20% of patients and in most cases can be detected on ultrasound. Micrometastases are present in up to 90%. Surgical management is altered in the presence of clinical lateral neck metastases. Total Thyroidectomy Central Neck Dissection! (ATA Guidelines 2015) Lateral Neck Dissection Kouvaraki, Surgery 2003 134:946; Stulak, Arch Surg 2006 141:489

Hay ID, Hutchinson ME, Gonzalez-Losada T, McIver B, et al. 2008; Surgery. Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period.

ATA Risk of Recurrence - Stratification Based on Initial Staging - 2009 LOW RISK Classic PTC / WDTC Complete resection No Extra-thyroidal extension. No vascular invasion INTERMEDIATE RISK Microscopic Extra-thyroidal extension Cervical Lymph node Mets Aggressive Histology Vascular invasion HIGH RISK Macroscopic gross Extra-thyroidal extension Incomplete tumor resection Thyroglobulin elevation Distant Mets

Pre-operative Comprehensive Neck Ultrasound The pre-operative neck US is for more than just cervical lymph nodes. Evaluate thyroid for signs indicative of high risk of aggressive disease Size of primary tumor. Suggestion of multifocality. Location of cancer (Adjacent to trachea or recurrent laryngeal nerve). Suspicion of extrathyroidal extension.

Value of pre-operative US 17 patients underwent reoperation for thyroid cancer at MD Anderson less than 6 months after initial surgery Pre-operative Ultrasound would likely have prevented 70% or the repeat operations. Kouvaraki Surgery 2004 136:1183

Recurrence (%) Clinical (PE) Lymph Node (LN) Metastases at Presentation: WORSE Outcome Local Recurrence Nodal Recurrence 20 15 LN positive LN negative 20 15 10 10 5 0 p<0.001 0 5 10 15 20 Years after initial surgery 5 0 p<0.00 1 0 5 10 15 20 Hay, Surgery 1992

US Detects about 40% of Pathologically Abnormal LNs US (-), PATHOLOGY (+) LN Metastases: NO IMPACT on Outcome Disease-free survival (%) 100 80 60 40 20 0 Pts WITH lat neck dissection Pts WITHOUT lat neck dissection p=ns 0 20 40 60 80 100 120 140 MONTHS Ito, Word J Surg 2004

Prophylactic lateral neck dissection does NOT improve recurrence free survival for patients with preoperative ultrasound negative for lymph nodes 1 Does lateral neck dissection alter the outcome for patients with preoperative ultrasound positive for lymph nodes? 1 Ito, World J Surg 2004

For macroscopic lateral lymph node metastases, modified neck dissection at time of initial thyroidectomy improves survival Noguchi, Arch Surg, 1998 133 276-280

Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer 2015 R21. Preoperative neck ultrasound for the contralateral lobe and cervical (central and bilateral) lymph nodes is recommended for all patients undergoing thyroidectomy for malignant cytologic findings on biopsy Recommendation B R22. Routine preoperative use of other imaging studies (CT, MRI, PET) is not recommended Recommendation E

Pre-operative Comprehensive Neck Ultrasound

Characteristics of Benign Lymph Nodes Flattened or oval shape Short / long axis < 0.5 Echogenic (hilar) line Vascular flow limited to hilum on Doppler Size varies with compartment and is less important than morphology. Border characteristics are also less important.

The Hilar Line A normal node can be split down the central hilum. Hilum contains fat and vessels A normal hilar line can be thin or thick, and can be central or eccentric/diagonal. The presence of a hilar line is reassuring, but it s absence in not considered suspicious.

Characteristics of Metastatic Lymph Nodes Calcifications Cystic necrosis Chaotic (peripheral) vascularization Rounded appearance Short/Long Axis > 0.5 Jugular displacement Absent echogenic (hilar) line

Disordered (peripheral) vascularity

Size > 3cm is associated with high risk of Recurrent disease

Jugular Displacement

Papillary Carcinoma Tall Cell Calcified Node

Papillary Carcinoma Node Chaotic Vascularity

Pre-operatively, central compartment lymph nodes are often much more difficult to visualize than lateral nodes, but should be investigated.

Investigation of the central compartment includes inferior to the thyroid.

Prognostic Indicators for Recurrence Nodal factors Lymph node metastases larger than 3 cm Extra-nodal extension More than 5 lymph nodes involved Aggressive Subtype (Tall Cell, TERT) High ratio of positive/removed nodes

ATA 2015 Guidelines Threshold size of Lymph Nodes for Biopsy

Should this solitary <0.7 cm metastatic node undergo biopsy prior to thyroidectomy?

Should this solitary 0.6 cm atypical node undergo biopsy prior to thyroidectomy?

The pre-operative neck US assesses more than just cervical lymph nodes. Evaluate the thyroid for signs indicative of high risk of aggressive disease Size of index thyroid lesion. Multifocality. Suspicion of extrathyroidal extension. Location of cancer Adjacent to trachea or RLN Isthmus lesions have higher rate of ETE

Preoperative Factors Associated with Higher Risk of Recurrence Lesion factors Extrathyroidal Extension (ETE) Location (Adjacent to RLN or trachea) Nodes - Number and size (ENE) Percent of tumor abutting thyroid capsule Signs or symptoms of invasion of RLN or trachea FNAB findings of high grade malignancy Patient factors Familial cancer, radiation

Extra-thyroidal extension is difficult to detect 79 Thyroid cancers evaluated for ETE on pre-op ultrasound, both 2D and 3D. Mean size 1 cm 71% <1cm 52/79 (66%) showed extra-thyroidal extension. ETE pt3 or pt4 Accuracy for predicting ETE 61% Increased to 68% if combined with 3D US Gweon HM, Son EJ, Youk GH, et al. Preoperative Assessment of Extrathyroidal Extension of Papillary Thyroid Carcinoma. JUM 2014; 33(5): 819-25

Extrathyroidal Extension into Strap Muscles

Suspicious for Extrathyroidal Extension

Suspicious for Extrathyroidal Extension

Extensive abutment of thyroid capsule suggests a high risk for ETE Lee CY, Kim SJ, Ko Kr, et al. Predictive factors for ETE of Papillary Thyroid Carcinoma Based on Preoperative Sonography. JUM 2014; 33:231-38

Pre-operative Ultrasound Conclusions A comprehensive central / lateral preoperative ultrasound should be performed in all patients undergoing surgery for thyroid cancer. Risk stratification should aid in planning the extent of thyroid surgery, as well as the need for a high volume thyroid surgeon. Consider biopsy of ANY suspicious nodes. Additional factors including: size, location, extrathyroidal extension and abutment ratio should be considered in surgical planning. Provide a detailed pre-operative map.